DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/k7pp7t/analysis_of_the) has announced the addition of the "Analysis of the Immunochemistry Market in Malaysia" report to their offering. The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Buy Singulair (Montelukast) with no Rx Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. About Dilantin (Phenytoin) with free Rx The demand for immunochemistry tests in tertiary care hospitals is high. Buy Minomycin (Minocycline) with free prescription Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry analyzers. Enalapril Public hospitals procure equipment using tenders, while reagents are purchased in batches 2-3 times a year. Prometrium (Progesterone) The demand for immunochemistry tests will grow, as communicable disease testing has increased and preventive tests are common. Key Topics Covered: 1. Buy Back Pain Relief online Executive Summary - Scope and Segmentation 2. http://allergy-opinion.blogspot.com Key Trends - Key Companies to Watch - Roche - Key Companies to Watch - Axon Scientific - Key Companies to Watch - BP Healthcare - Key Companies to Watch - Snibe 3. Overview of the Malaysian Healthcare Market - Overview of Healthcare Expenditure in Malaysia - Overview of Population Forecast in Malaysia - Growing Demand for and Affordability of Quality Healthcare Services - Growth in Malaysian Hospitals - Parallel Public and Private Healthcare Sectors in Malaysia - Classification of Healthcare Services (HCS) in Malaysia - Access to Public Secondary and Tertiary Service Care - Principal Cause of Death in Public Hospitals - Principal Cause of Death in Private Hospitals 4. Overview of the Malaysian Hospital Market and Trends in the Immunochemistry Testing Market - Malaysian Hospitals - Market Overview - Category High Public Hospitals (>650 Beds per Hospital) - Key States - Category Medium Public Hospitals (150-650 Beds) - Key States - Category Low Public Hospitals (< 150 Beds) - Key States - Malaysian IVD Market - Market Segmentation - Customer Segmentation in the Malaysian Immunochemistry Market - Segmentation of Key Immunochemistry Tests in Public Hospitals - Type of Tests - Top 3 Immunochemistry Tests in Demand in Malaysian Hospitals - Usage Pattern of Immunochemistry Equipment - In spite of prices of Healthcare services will get impacted due to GST, the volume of test is unlikely to be effected - Demand for Automated Immunochemistry Equipment Versus Conventional End User s Perspective - Procurement Process of Immunochemistry Equipment in Public Hospitals - Procurement Process of Immunochemistry Equipment in Private Hospitals and Diagnostic Laboratories 5. Competitor Playbook - Overview of Key Competitors in the Immunochemistry Market in Malaysia - Revenue Forecast - Demand for Immunochemistry Equipment in Malaysia - A Distributor s Perspective - Top 3 Competitors - Manufacturers - Segment Analysis of Competitors in the Immunochemistry Market - Key Distributors in the Malaysian Immunochemistry Market 6. Opportunities, Drivers, and Restraints in the Malaysian Immunochemistry Market - Opportunity for Automated Equipment Manufacturers - New Public Hospitals in Malaysia - New Private Hospitals in Malaysia - Key Market Drivers - Key Market Restraints 7. Future Trends in the Malaysian Immunochemistry Market For more information visit .researchandmarkets.com/research/k7pp7t/analysis_of_the

Global Sports Medicine Market (by Segment) and Company Analysis to 2020

DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/rwd7br/global_sports) has announced the addition of the "Global Sports Medicine Market (By Segment) and Company Analysis to 2020" report to their offering. The global sports medicine market has been continuously rising over the year and has a rosy future ahead. About Revia (Naltrexone) without Rx Sports medicine focuses on helping people improve their athletic performance, recover from injury and prevent future injuries. About Enablex (Darifenacin) with free Rx It is a fast-growing health care field, because health workers who specialize in sports medicine help many regular people as well as athletes. About Tinidazole () with free Rx The major driving factors for the sports medicine market are the aging population, increasing participation in sports activities, technological advancements in the field of sports medicine, rising awareness among athletes regarding physical and health fitness and the increased incidence of sport related injuries to the athletes and the long recovery periods involved as a cause of the injury. About Elavil The lack of favorable reimbursement policies to the sport related injuries and the high cost of sports medicine has been a major challenge faced by the sports medicine market. Global Sports Medicine Market Segment Wise Analysis: In the Global sports medicine, Shoulder injuries accounts for the maximum share of the market. Buy Retrovir (Zidovudine) The Knee injuries is the second leading segment in 2014 being followed by Mechanical Resection. Buy Appetite Suppressant online Access stands at the fourth spot while RF Resection is holding the fifth spot in the global sports medicine market. Global Sports Medicine Revenue Company Wise Analysis: Arthrex is the global leader in the sports medicine market with Smith & Nephew in the second position. http://asthmareview.wordpress.com DePuy Synthes Mitek holds the third spot in the global sports medicine market. Stryker is the fourth leading player in global sports medicine market in 2014. ConMed Linvatec and Biomet are competing closely with each other in order to grab maximum share of the pie. The Sports Medicine Market covered in the report is analyzed from 2 viewpoints follows: 1. Joint Repair - 3 Segments Covered 1. Hip 2. Knee 3. Shoulder 2. Arthroscopic Enabling Technologies - 5 Segments Covered 1. Video 2. Access 3. RF Resection 4. Mechanical Resection 5. Others The 8 Companies analyzed in the reports are: 1. Arthrex 2. Arthrocare 3. Biomet (Acquired by Zimmer) 4. DePuy Mitek 5. ConMed Linvatec 6. Smith & Nephew 7. Stryker 8. Others Key Topics Covered: 1. Executive Summary 2. Global Sports Medicine Market & Forecast (2012 - 2020) 3. Global Sports Medicine Market Share & Forecast - Segment Wise (2012 - 2020) 4. Global Sports Medicine Market Share & Forecast - Company Wise (2012 - 2020) 5. Global Sports Medicine Market & Forecast - Segment Wise (2012 - 2020) 6. Global Sports Medicine Revenue & Forecast - Company Wise (2012 - 2020) 7. Global Sports Medicine Market - Major Deals 8. Global Sports Medicine Market - Driving Factors 9. Global Sports Medicine Market - Challenges For more information visit .researchandmarkets.com/research/rwd7br/global_sports

DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/qn2tn9/investigation) has announced the addition of the "Investigation Report on China s Polyene Phosphatidyl Choline Market, 2010-2019" report to their offering. China is recognized worldwide as one of the countries with a high incidence of liver disease. Buy Norlutate (Norethindrone Acetate) with free prescription Viral hepatitis, fatty liver, alcoholic liver disease, medicamentous liver lesion and liver cancer have posed a severe threat to the Chinese people s health. Buy Janumet (Sitagliptin Metformin) with no prescription In recent years, drugs for liver disease that rank second to proton pump inhibitor in drugs for the digestive system have gradually become a variety with large sales value which occupies 30% of the total sales value of all ten categories of drugs for digestive system. Among all the drugs for liver disease, polyene phosphatidyl choline is the natural diglyceride of cholinephosphoric acid and unsaturated fatty acids which can protect hepatocyte from lesion, alleviate inflammation reaction and improve the detoxification of the liver. Ovral (Ethinyl estradiol / Norgestrel) with free Rx And it is used for the treatment of hepatitis (acute and chronic), hepatic cirrhosis and poisoning with certain efficacy in the clinic. Buy Dothiepin with free prescription First developed by Sanofi, polyene phosphatidyl choline has been marketed under the trade name of Essentiale Forte. Some local enterprises are already capable of producing polyene phosphatidyl choline APIs and injections. Sustiva (Efavirenz) with no Rx For example, Sichuan Haisco Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd have been approved to produce polyene phosphatidyl choline under the trade name of Yibisheng. Buy Weight Gainers online Imported drugs mainly come from Sanofi (Beijing), Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Sanofi-Aventis Ukraine LLc and A.Nattermann & Cie.GmbH. The growth of polyene phosphatidyl choline has accelerated since 2006, making it occupy an important proportion of the adjuvant drugs for liver disease. http://medicalhelper.wordpress.com According to this survey, the sales value of polyene phosphatidyl choline in sample hospitals rose from less than CNY 60 million in 2005 to over CNY 400 million in 2014 and CAGR during this period reached 25%. With the lifestyle changes brought about by economic development, the incidence of liver disease in China has kept increasing. Therefore, the market size of polyene phosphatidyl choline is expected to continue to grow in the next few years in China. Key Topics Covered: 1 Related Concepts of Polyene Phosphatidyl Choline 2 Market Profile of Polyene Phosphatidyl Choline in China 3 Survey on Sales Status of Polyene Phosphatidyl Choline in China, 2010-2014 4 Survey on Market Share of Major Manufacturers of Polyene Phosphatidyl Choline in China, 2010-2014 5 Survey on Dosage Forms of Polyene Phosphatidyl Choline in China, 2010-2014 6 Reference Price of Polyene Phosphatidyl Choline in Chinese Hospitals in 2014 7 Major Manufacturers of Polyene Phosphatidyl Choline in Chinese Market, 2010-2014 8 Market Outlook of Polyene Phosphatidyl Choline in China, 2015-2019 Companies Mentioned - Shenzhen Sanofi Pasteur Biological Products Co., Ltd - Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd - Chengdu Tiantaishan Pharmaceutical Co., Ltd - Aventis Pharma S.p.A. For more information visit .researchandmarkets.com/research/qn2tn9/investigation